Loading...
Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis
Phase I clinical trials exploring the use of autologous mesenchymal stem cell (MSC) therapy for the treatment of multiple sclerosis (MS) have begun in a number of centers across the world. MS is a complex and chronic immune-mediated and neurodegenerative disease influenced by genetic susceptibility...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3234364/ https://ncbi.nlm.nih.gov/pubmed/21864075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ern.11.113 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|